Simvastatin impairs hippocampal synaptic plasticity and cognitive function in mice

Mol Brain. 2021 Feb 24;14(1):41. doi: 10.1186/s13041-021-00758-x.

Abstract

Lipophilic statins which are blood brain barrier (BBB) permeable are speculated to affect the cholesterol synthesis and neural functions in the central nervous system. However, whether these statins can affect cholesterol levels and synaptic plasticity in hippocampus and the in vivo consequence remain unclear. Here, we report that long-term subcutaneous treatments of simvastatin significantly impair mouse hippocampal synaptic plasticity, reflected by the attenuated long-term potentiation of field excitatory postsynaptic potentials. The simvastatin administration causes a deficiency in recognition and spatial memory but fails to affect motor ability and anxiety behaviors in the mice. Mass spectrometry imaging indicates a significant decrease in cholesterol intensity in hippocampus of the mice receiving chronic simvastatin treatments. Such effects of simvastatin are transient because drug discontinuation can restore the hippocampal cholesterol level and synaptic plasticity and the memory function. These findings may provide further clues to elucidate the mechanisms of neurological side effects, especially the brain cognitive function impairment, caused by long-term usage of BBB-permeable statins.

Keywords: Cholesterol; Cognition; Hippocampus; Mass spectrometry imaging; Simvastatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Cholesterol / metabolism
  • Cognition / drug effects
  • Cognition / physiology*
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • Long-Term Potentiation / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology*
  • Recognition, Psychology / drug effects
  • Simvastatin / pharmacology*
  • Spatial Memory / drug effects

Substances

  • Cholesterol
  • Simvastatin